The vaccine maker and its accomplice BioNTech will submit the information to regulators within the US and Europe.

Agencies | , Washington/brussels

PUBLISHED ON APR 01, 2021 02:49 AM IST

Pfizer has stated that its Covid-19 vaccine was 100% efficient in a final-stage trial in kids aged 12 to 15 years, a discovering that might pave the best way for teenagers and pre-teens to get photographs earlier than the following college yr.

The vaccine is already authorised within the US for individuals aged 16 and above. Pfizer and its accomplice BioNTech stated they deliberate to submit the information to regulators within the US and Europe as quickly as potential, in search of to amend their vaccine authorisations to incorporate the youthful age group.

In the research of two,260 adolescents, the vaccine produced antibodies in opposition to Covid-19 that exceeded the extent seen in vaccinated younger adults, Pfizer and BioNTech stated. All 18 circumstances of Covid within the research had been in adolescents who had been administered a placebo, the businesses stated.

EU: No danger from AZ shot

Experts probing hyperlinks between the AstraZeneca vaccine and blood clots have discovered no particular danger components, together with age, the EU’s drug regulator stated. The European Medicines Agency stated its security committee is predicted to difficulty an “updated recommendation” on the vaccine subsequent week.

WHO nod for China jabs

Two Chinese jabs are protected and efficient, WHO consultants stated after reviewing partial information. Experts on the WHO didn’t difficulty any recommendation on methods to use the jabs, saying they’ll wait till a call was taken on granting them emergency licences. The consultants stated the vaccines from Sinovac and Sinopharm “lacked data” for older age teams.

Covid vaccine for animals

Russia has registered the world’s first Covid vaccine for animals, saying it’s wanted for disrupting mutations. Russia stated the vaccine has been examined on canines, cats, mink and foxes.

Close


Follow us on Google News

VNAP News Portal